ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Repros Initiates Two Head to Head Studies of Androxal(R) Versus the Leading Topical T
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 4750" data-attributes="member: 3"><p>It is very interesting to me that the endpoints of this study do not include improvement in sexual function. Clomiphene has shown not to improve it! Androxal is a clomiphene (Clomid) isomer (since Clomid is a generic, the company changed the molecule a tiny bit to patent it and get approval)</p><p></p><p>"The primary endpoint of the study is the comparison of Androxal to the topical gel from the perspective of normalizing testicular function. As such, men must exhibit 24 hour average testosterone levels in the normal range (300-1040 ng/dL), and an average of two sperm counts at the end of the study must remain above the lower bound of the 95% confidence interval for normal male fertility (15 million/mL). Based on results from previous Repros studies, the Company believes the two trials are suitably powered (90% power, alpha=0.05) to demonstrate the key difference between restoration of normal testicular function with Androxal versus the T replacement-induced suppression of male reproductive organ activity."</p><p></p><p><a href="http://www.marketwatch.com/story/repros-initiates-two-head-to-head-studies-of-androxalr-versus-the-leading-topical-testosterone-gel-2014-01-08?reflink=MW_news_stmp" target="_blank">http://www.marketwatch.com/story/repros-initiates-two-head-to-head-studies-of-androxalr-versus-the-leading-topical-testosterone-gel-2014-01-08?reflink=MW_news_stmp</a></p><p></p><p>Previous post on excelmale about this company: <a href="https://www.excelmale.com/forum/threads/811-Repros-says-FDA-seeks-more-studies-for-clomiphene-drug?highlight=repros" target="_blank">https://www.excelmale.com/forum/threads/811-Repros-says-FDA-seeks-more-studies-for-clomiphene-drug?highlight=repros</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 4750, member: 3"] It is very interesting to me that the endpoints of this study do not include improvement in sexual function. Clomiphene has shown not to improve it! Androxal is a clomiphene (Clomid) isomer (since Clomid is a generic, the company changed the molecule a tiny bit to patent it and get approval) "The primary endpoint of the study is the comparison of Androxal to the topical gel from the perspective of normalizing testicular function. As such, men must exhibit 24 hour average testosterone levels in the normal range (300-1040 ng/dL), and an average of two sperm counts at the end of the study must remain above the lower bound of the 95% confidence interval for normal male fertility (15 million/mL). Based on results from previous Repros studies, the Company believes the two trials are suitably powered (90% power, alpha=0.05) to demonstrate the key difference between restoration of normal testicular function with Androxal versus the T replacement-induced suppression of male reproductive organ activity." [URL]http://www.marketwatch.com/story/repros-initiates-two-head-to-head-studies-of-androxalr-versus-the-leading-topical-testosterone-gel-2014-01-08?reflink=MW_news_stmp[/URL] Previous post on excelmale about this company: [URL]https://www.excelmale.com/forum/threads/811-Repros-says-FDA-seeks-more-studies-for-clomiphene-drug?highlight=repros[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Repros Initiates Two Head to Head Studies of Androxal(R) Versus the Leading Topical T
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top